Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel
T De Witte, D Bowen, M Robin… - Blood, The Journal …, 2017 - ashpublications.org
An international expert panel, active within the European Society for Blood and Marrow
Transplantation, European LeukemiaNet, Blood and Marrow Transplant Clinical Trial Group …
Transplantation, European LeukemiaNet, Blood and Marrow Transplant Clinical Trial Group …
Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet
L Malcovati, E Hellström-Lindberg… - Blood, The Journal …, 2013 - ashpublications.org
Within the myelodysplastic syndrome (MDS) work package of the European LeukemiaNet,
an Expert Panel was selected according to the framework elements of the National Institutes …
an Expert Panel was selected according to the framework elements of the National Institutes …
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase …
P Fenaux, GJ Mufti, E Hellstrom-Lindberg… - The lancet …, 2009 - thelancet.com
Background Drug treatments for patients with high-risk myelodysplastic syndromes provide
no survival advantage. In this trial, we aimed to assess the effect of azacitidine on overall …
no survival advantage. In this trial, we aimed to assess the effect of azacitidine on overall …
Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†☆
P Fenaux, D Haase, V Santini, GF Sanz… - Annals of …, 2021 - annalsofoncology.org
Myelodysplastic syndromes (MDS) are clonal haematopoietic stem cell (HSC) disorders
predominating in the elderly, characterised by ineffective haematopoiesis leading to blood …
predominating in the elderly, characterised by ineffective haematopoiesis leading to blood …
[PDF][PDF] Comorbidity and disease status–based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic …
ML Sorror, BM Sandmaier, BE Storer… - Journal of Clinical …, 2007 - researchgate.net
Comorbidity and Disease Status–Based Risk Stratification of Outcomes Among Patients With
Acute Myeloid Leukemia or Myelodyspla Page 1 Comorbidity and Disease Status–Based Risk …
Acute Myeloid Leukemia or Myelodyspla Page 1 Comorbidity and Disease Status–Based Risk …
Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA …
R Martino, S Iacobelli, R Brand, T Jansen… - Blood, 2006 - ashpublications.org
In this multicenter retrospective study, the outcomes of 836 patients with myelodysplastic
syndrome (MDS) who underwent transplantation with a human leukocyte antigen (HLA) …
syndrome (MDS) who underwent transplantation with a human leukocyte antigen (HLA) …
[HTML][HTML] Factors affecting response and survival in patients with myelodysplasia treated with immunosuppressive therapy
EM Sloand, CO Wu, P Greenberg… - Journal of clinical …, 2008 - ncbi.nlm.nih.gov
Purpose Marrow failure in some patients with myelodysplastic syndrome (MDS) responds to
immunosuppressive treatment (IST), but long-term outcome after IST has not been …
immunosuppressive treatment (IST), but long-term outcome after IST has not been …
Acute myeloid leukemia: the good, the bad, and the ugly
A Kuykendall, N Duployez, N Boissel… - American Society of …, 2018 - ascopubs.org
Acute myeloid leukemia (AML) was initially subdivided according to morphology (the French-
American-British system), which proved helpful in pathologic categorization. Subsequently …
American-British system), which proved helpful in pathologic categorization. Subsequently …
Myelodysplastic syndromes
PL Greenberg, E Attar, JM Bennett… - Journal of the National …, 2011 - jnccn.org
The myelodysplastic syndromes (MDS) represent myeloid clonal hemopathies with relatively
heterogeneous spectrums of presentation. The major clinical problems in these disorders …
heterogeneous spectrums of presentation. The major clinical problems in these disorders …
Myelodysplastic syndromes
PL Greenberg, NS Young… - ASH Education Program …, 2002 - ashpublications.org
The myelodysplastic syndromes (MDS) are characterized by hemopoietic insufficiency
associated with cytopenias leading to serious morbidity plus the additional risk of leukemic …
associated with cytopenias leading to serious morbidity plus the additional risk of leukemic …